The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 18, 2022

Filed:

Feb. 19, 2019
Applicant:

Immunores-therapeutics, Llc, Natchez, MS (US);

Inventors:

Ronald Howard Lane, Natchez, MS (US);

Barry Davignon, Terre Haute, IN (US);

Peter Heath, Sussex, WI (US);

Assignee:

ImmunoRes-Therapeutics, LLC, Indianapolis, IN (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61M 1/34 (2006.01); A61K 35/14 (2015.01); A61L 2/00 (2006.01); A61L 2/20 (2006.01); A61M 1/02 (2006.01); A61M 1/36 (2006.01); A61L 2/24 (2006.01); A61L 2/26 (2006.01);
U.S. Cl.
CPC ...
A61M 1/3486 (2014.02); A61K 35/14 (2013.01); A61L 2/0005 (2013.01); A61L 2/0094 (2013.01); A61L 2/20 (2013.01); A61M 1/025 (2013.01); A61M 1/0259 (2013.01); A61M 1/0272 (2013.01); A61M 1/0281 (2013.01); A61M 1/3482 (2014.02); A61M 1/3687 (2013.01); A61L 2/202 (2013.01); A61L 2/24 (2013.01); A61L 2/26 (2013.01); A61L 2202/22 (2013.01); A61M 2202/0216 (2013.01);
Abstract

The present disclosure provides apparatuses and systems for delivering a measureable absorbed-dose of a gaseous activating agent to a fluid including a biological liquid and/or cells. The apparatuses or systems include a gas-fluid contact device configured to controllably rotate or oscillate a control member having an interior surface in contact with the fluid and a control system configured to control rotation or oscillation of the contact member by the gas-fluid contact device. In some embodiments, the control system is further configured to control absorption of the gaseous activating agent by the fluid. The present disclosure also provides methods of treating a fluid including a biological liquid or cells with a gaseous activating agent to controllably activate the fluid.


Find Patent Forward Citations

Loading…